DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+11.8%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.54B
AUM Growth
+$2.54B
(+8.3%)
Cap. Flow
+$23M
Cap. Flow
% of AUM
0.9%
Top 10 Holdings %
Top 10 Hldgs %
37.92%
Holding
129
New
21
Increased
16
Reduced
23
Closed
20
Top Buys
| 1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$38M |
| 2 |
ADPT
Adeptus Health Inc.
ADPT
|
$33.3M |
| 3 |
DBVT
DBV Technologies
DBVT
|
$30.2M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$29.1M |
| 5 |
Glaukos
GKOS
|
$28.7M |
Top Sells
| 1 |
GSK
GSK
|
$67.9M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$35.7M |
| 3 |
AET
Aetna Inc
AET
|
$27.5M |
| 4 |
McKesson
MCK
|
$27.5M |
| 5 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
$27.4M |
Sector Composition
| 1 | Healthcare | 68.67% |
| 2 | Financials | 3.21% |
| 3 | Industrials | 0.75% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Veracyte
VCYT
$2.41B
| – | – |
-165,097
| Closed | -$892K |
|
102
Trupanion
TRUP
$1.9B
| – | – |
-155,236
| Closed | -$1.53M |
|
103
Tonix Pharmaceuticals
TNXP
$243M
| – | – |
0
-1,315,551
| -100% | -$3.17M |
|
|
SAGE
104
DELISTED
Sage Therapeutics
SAGE
| – | – |
-1,113,654
| Closed | -$35.7M |
|
|
PTN
105
DELISTED
Palatin Technologies
PTN
| – | – |
-985,693
| Closed | -$532K |
|
106
Pfizer
PFE
$141B
| – | – |
-25,000
| Closed | -$741K |
|
107
Novavax
NVAX
$1.2B
| – | – |
-2,456,261
| Closed | -$12.7M |
|
108
MacroGenics
MGNX
$121M
| – | – |
-517,920
| Closed | -$9.71M |
|
|
109
McKesson
MCK
$85.9B
| – | – |
-175,000
| Closed | -$27.5M |
|
|
110
GSK
GSK
$79.3B
| – | – |
-1,675,385
| Closed | -$67.9M |
|
111
Elevance Health
ELV
$72.4B
| – | – |
-102,000
| Closed | -$14.2M |
|
112
Cidara Therapeutics
CDTX
$1.61B
| – | – |
-68,779
| Closed | -$873K |
|
|
WMGI
113
DELISTED
Wright Medical Group Inc
WMGI
| – | – |
-30,000
| Closed | -$498K |
|